๐Ÿ‡บ๐Ÿ‡ธ HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026

๐Ÿ‡บ๐Ÿ‡ธ

Findings demonstrate HERV-K is required for senescence-associated inflammation in metabolically challenged cells and is reactivated in plasma of subjects living with obesity COPENHAGEN, Denmark and NEW YORK, July 15, 2026 /PRNewswire/ — HERVolution Therapeutics ApS, a biotechnology…

Source: prnewswire

Country: United States